Ying Zou

Associate Professor

20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ying Zou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Telomere Medicine & Life Sciences
Telomerase Medicine & Life Sciences
Chromosomes Medicine & Life Sciences
Chromosome Aberrations Medicine & Life Sciences
Genetic Translocation Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Intellectual Disability Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma

Duong, V. H., Holtzman, N. G., Koka, R., Singh, Z. N., Zou, Y., Emadi, A., Rapoport, A. P., Kocoglu, M. H., Baer, M. R. & Badros, A. Z., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Second Primary Neoplasms
Multiple Myeloma

Cryptic ETV6–PDGFRB fusion in a highly complex rearrangement of chromosomes 1, 5, and 12 due to a chromothripsis-like event in a myelodysplastic syndrome/myeloproliferative neoplasm

Singh, Z. N., Richards, S., El Chaer, F., Duong, V. H., Gudipati, M. A., Waters, E. O., Koon, S., Webley, M., Pitel, B., Hoppman, N. L., Baer, M. R. & Zou, Y., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1304-1307 4 p.

Research output: Contribution to journalLetter

Platelet-Derived Growth Factor beta Receptor
Chromosomes, Human, Pair 12
Chromosomes, Human, Pair 5
Chromosomes, Human, Pair 1
Myelodysplastic Syndromes

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation

Adige, S., Lapidus, R. G., Carter-Cooper, B. A., Duffy, A., Patzke, C., Law, J. Y., Baer, M. R., Ambulos, N. P., Zou, Y., Bentzen, S. M. & Emadi, A., Jun 1 2019, In : Cancer Chemotherapy and Pharmacology. 83, 6, p. 1105-1112 8 p.

Research output: Contribution to journalArticle

Idarubicin
Daunorubicin
Acute Myeloid Leukemia
Meta-Analysis
Clinical Trials

Refractory postallogeneic stem cell transplant pure red cell aplasia in remission after treatment with daratumumab

Bathini, S., Holtzman, N. G., Koka, R., Singh, Z., Wilding, E., Zou, Y., Ruehle, K., Kocoglu, M. H., Badros, A., Hardy, N., Yared, J., Rapoport, A. P., Fontaine, M., Emadi, A., El Chaer, F. & Dahiya, S., Aug 1 2019, In : American journal of hematology. 94, 8, p. E216-E219

Research output: Contribution to journalLetter

Pure Red-Cell Aplasia
Stem Cells
Transplants
daratumumab

Stable transmission of complex chromosomal rearrangements involving chromosome 1q derived from constitutional chromoanagenesis

Gudipati, M. A., Waters, E., Greene, C., Goel, N., Hoppman, N. L., Pitel, B. A., Webley, M. R. & Zou, Y., Oct 31 2019, In : Molecular Cytogenetics. 12, 1, 43.

Research output: Contribution to journalArticle

Open Access
Chromosomes
Chromosomes, Human, Pair 1
Encephalomalacia
Chromosome Breakpoints
Patent Ductus Arteriosus